HIVR4P 2014: Positive Response to Gift Tokens for Undetectable Viral Load Trial
- Details
- Category: Cascade of Care
- Created on Tuesday, 25 November 2014 00:00
A U.S. study presented at last month’s HIV Research for Prevention conference found generally positive responses among people with HIV and clinic staff to a trial that used $70 gift tokens as an incentive for people to maintain an undetectable viral load. However, the study found that only just under half of patients had an accurate understanding of what viral load was, and that this did not improve during the study.
Coverage of HIV Research for Prevention Conference (HIVR4P 2016)
- Details
- Category: HIV Prevention
- Created on Saturday, 22 October 2016 00:00
HIVandHepatitis.com coverage of the 2016 HIV Research for Prevention Conference (HIVR4P 2016), October 17-21, in Chicago.
Conference highlights include current and experimental pre-exposure prophylaxis (PrEP), microbicide rings and other options, and investigational HIV vaccines.
Full listing of coverage by topic
10/22/16
HIVR4P 2014: Research for Prevention Conference Opens with Real Hope for HIV Vaccine
- Details
- Category: HIV Prevention
- Created on Friday, 31 October 2014 00:00
"There’s only one Berlin Patient still. But by this time next year he will at least be joined by 40-50 Portland monkeys." These were the words of vaccine researcher Louis Picker, summarizing in quotable form why the outlook for the development of an effective HIV vaccine is brighter than it has been for years, in a satellite session in advance of the HIV Research for Prevention conference (R4P) in Cape Town, South Africa.
Coverage of HIV Research for Prevention Conference (HIVR4P 2014)
- Details
- Category: HIV Prevention
- Created on Tuesday, 04 November 2014 00:00
HIVandHepatitis.com coverage of the HIV Research for Prevention Conference (HIVR4P 2014), October 28-31, in Cape Town.
This conference -- combining the previous HIV Vaccines and Microbicides meetings -- includes all aspects of HIV prevention including experimental vaccines, microbicide gels and rings, and pre-exposure prophylaxis (PrEP).
Full listing of coverage by topic
11/4/14
HIV Research for Prevention Conference Features Advances in Vaccines, Microbicides, PrEP
- Details
- Category: HIV Prevention
- Created on Tuesday, 28 October 2014 00:00
The first HIV Research for Prevention -- or HIV R4P -- conference takes place this week in Cape Town, bringing together more than 1300 leading researchers, policymakers, and advocates working on interventions such as HIV vaccines, microbicides, antiretroviral treatment as prevention (TasP), and new forms of pre-exposure prophylaxis (PrEP). The conference incorporates the previously separate HIV vaccine and microbicide meetings as biomedical prevention technologies have converged.
More Articles...
- HIVR4P 2014: HIV Prevention Requires Supporting and Respecting Key Affected Populations
- HIVR4P 2014: Injectable Cabotegravir Makes Progress, Doubts About Injectable Rilpivirine
- HIVR4P 2014: Model Suggests More Frequent Truvada PrEP Needed for Vaginal vs Anal Sex
- HIVR4P 2014: Vaginal Rings Show Promise for HIV Prevention
- HIVR4P 2014: Tenofovir Gel Associated with Lower Herpes Simplex Risk for Women
- HIVR4P 2014: The Immunity Project -- An Open-Access T-Cell Vaccine for HIV Infection